IGFBP2 and glioma: In our investigation, the four-gene prognostic signature (MAOB, IGFBP2, SERPINA1 and LGR6) we identified demonstrates significant involvement in multifaceted oncogenic pathways, particularly exhibiting strong correlations with tumor proliferation, metastatic potential, and invasive behavior in WHO grade II/III gliomas.